QIC BioVentures Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
13
- Exits
-
8
QIC BioVentures General Information
Company Description
QIC BioVentures was established by the Queensland Investment Corporation in 2002 and was a venture capital arm that specialized in biotechnology sectors. The funds invested in listed and unlisted companies which are commercializing Australian discoveries in drugs, device and diagnostic sectors. As of September 26, 2012, QIC terminated the investment activities of Queensland BioCapital Funds, all remaining activities and employees were transferred to QIC Private Capital, a subsidiary of Queensland Investment Corporation.
Business Details
Year Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- Level 5 Central Plaza Two
- 66 Eagle Street, GPO Box 2242
- Brisbane, Queensland 4001
- Australia
QIC BioVentures Investments (13)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics | 10-Jul-2015 | Later Stage VC | Biotechnology | Profitable | ||
| Hatchtech | 31-Oct-2013 | Pharmaceuticals | Generating Revenue | |||
| Gelesis | 08-Jun-2011 | Drug Discovery | Generating Revenue | |||
| Hatchtech | 26-Oct-2010 | Pharmaceuticals | Generating Revenue | |||
| Tokai Pharmaceuticals | 21-Oct-2008 | Pharmaceuticals | Generating Revenue | |||
| Xenome | 27-Nov-2007 | Biotechnology | Out of Business | |||
| Tokai Pharmaceuticals | 07-Jun-2007 | Pharmaceuticals | Generating Revenue | |||
| Protagonist Therapeutics | 18-Sep-2006 | Biotechnology | Profitable | |||
| Xbio Systems | 02-Apr-2006 | Early Stage VC | Business/Productivity Software | Out of Business | ||
| Advent Pharmaceuticals | 15-Jul-2005 | Early Stage VC | Drug Discovery | Generating Revenue |
QIC BioVentures Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Gelesis | 13-Jan-2022 | Reverse Merger | |
| Advent Pharmaceuticals | 01-Dec-2018 | ||
| Hatchtech | 05-Sep-2016 | ||
| Protagonist Therapeutics | 11-Aug-2016 | ||
| Xbio Systems | 01-Apr-2016 | ||
| Tokai Pharmaceuticals | 17-Sep-2014 | ||
| Adipogen Pharmaceuticals | 29-Nov-2007 | Merger/Acquisition | |
| Xenome | Bankruptcy: Liquidation |
QIC BioVentures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
QIC BioVentures FAQs
-
What is QIC BioVentures?
QIC BioVentures was established by the Queensland Investment Corporation in 2002 and was a venture capital arm that specialized in biotechnology sectors.
-
When was QIC BioVentures founded?
QIC BioVentures was founded in 2002.
-
Where is QIC BioVentures headquartered?
QIC BioVentures is headquartered in Brisbane, Australia.
-
How many investments has QIC BioVentures made?
QIC BioVentures has made 13 investments.
-
What has QIC BioVentures invested in?
QIC BioVentures has made numerous investments in companies like Protagonist Therapeutics, Hatchtech, and Gelesis within the Biotechnology, Pharmaceuticals, and Drug Discovery industries.
-
What has QIC BioVentures invested in recently?
QIC BioVentures's latest investment was on 10-Jul-2015 in Protagonist Therapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
